{
    "root": "b2fa51f4-e418-4113-bdd8-17f33ba250b7",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Olanzapine",
    "value": "20250221",
    "ingredients": [
        {
            "name": "OLANZAPINE",
            "code": "N7U69T4SZR"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "TARTARIC ACID",
            "code": "W4888I119H"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I"
        }
    ],
    "indications": "olanzapine injection atypical antipsychotic indicated : \u2022 treatment acute agitation associated schizophrenia bipolar mania . ( 1.4 ) \u2022 efficacy established three 1-day trials adults . ( 14.3 )",
    "contraindications": "agitation associated schizophrenia bipolar mania adults ( 2.4 ) im : 10 mg ( 5 mg 7.5 mg clinically warranted ) assess orthostatic hypotension prior subsequent dosing ( max . 3 doses 2 4 hrs apart )",
    "warningsAndPrecautions": null,
    "adverseReactions": "\u2022none olanzapine injection monotherapy . \u2022for information lithium valproate , refer section package inserts products .",
    "indications_original": "Olanzapine for injection is an atypical antipsychotic indicated: \u2022 Treatment of acute agitation associated with schizophrenia and bipolar I mania. ( 1.4 ) \u2022 Efficacy was established in three 1-day trials in adults. ( 14.3 )",
    "contraindications_original": "Agitation associated with Schizophrenia and Bipolar I Mania in adults ( 2.4 ) IM: 10 mg (5 mg or 7.5 mg when clinically warranted) Assess for orthostatic hypotension prior to subsequent dosing (max. 3 doses 2 to 4 hrs apart)",
    "adverseReactions_original": "\u2022None with olanzapine for injection monotherapy.\n                     \n                        \u2022For specific information about the contraindications of lithium or valproate, refer to the Contraindications section of the package inserts for these other products."
}